Magazine Article | November 1, 2022

Pioneering In-House, Continuous Manufacturing

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

Being a layperson in bioproduction, I wanted to know more about the concept and reality of continuous manufacturing (CM), and especially why a company would elect to build its own CM capability in-house. A natural candidate for educating me is an advocate for companies using CM in whatever setting fit their needs. She is Patricia (Trish) Hurter, a pharma manufacturing veteran and now CEO of Lyndra Therapeutics.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: